Cargando…
Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes
BACKGROUND: Hyaluronan (HA), a major component of the extracellular matrix, has been proven to play a crucial role in tumor progression. However, it remains unknown whether HA exerts any effects in myelodysplastic syndromes (MDS). METHODS: A total of 82 patients with MDS and 28 healthy donors were i...
Autores principales: | Fei, Cheng-Ming, Guo, Juan, Zhao, You-Shan, Zhao, Si-Da, Zhen, Qing-Qing, Shi, Lei, Li, Xiao, Chang, Chun-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109310/ https://www.ncbi.nlm.nih.gov/pubmed/30143008 http://dx.doi.org/10.1186/s12967-018-1614-4 |
Ejemplares similares
-
Role of hyaluronan in regulating self-renewal and osteogenic differentiation of mesenchymal stromal cells and pre-osteoblasts
por: Asparuhova, Maria B., et al.
Publicado: (2020) -
The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome
por: Zheng, Likun, et al.
Publicado: (2022) -
Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
por: Koltai, Tomas, et al.
Publicado: (2021) -
Sulfated hyaluronan alters fibronectin matrix assembly and promotes osteogenic differentiation of human bone marrow stromal cells
por: Vogel, Sarah, et al.
Publicado: (2016) -
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
por: Mattiucci, Domenico, et al.
Publicado: (2018)